Executive Medical Director, Specialty and Pipeline

Bayer•Tulsa, OK

1d•$248,000 - $372,000

About The Position

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where 'Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice. Executive Medical Director, Specialty and Pipeline As a critical member of the US Medical Affairs team, the Executive Medical Director, Specialty and Pipeline will be responsible for the oversight of development and execution of high-quality medical strategy for Bayer pipeline portfolio through scientific leadership, external engagement, and cross-functional influence to advance evidence generation, medical education, and development of medical affairs strategy to support commercialization strategic plans of the portfolio.

Requirements

M.D. or D.O. required.
Agility and ability to flex into different therapeutic areas is necessary for success in this role.
Clinically relevant work experience or independent research experience or equivalent or experience in a pharmaceutical related industry.
Experience working in or deep understanding of in-hospital consideration in US healthcare delivery.
Deep understanding of clinical trial design, analysis and interpretation as well as the principles of observational studies and health economics/ outcomes research.
Robust understanding of regulatory and market access considerations and triangulating those to implications on clinical trial design and clinical care delivery.
Proven ability for strategic planning along with operations skill and experience related to clinical research involving both single and multiple centers.
Strong ability to quickly build meaningful and trusting relationships, both internally and externally to the organization.
Understanding of the drug development process over different stages.
Strong ability to connect and collaborate across different functions and background, both internally and externally to the organization.
Innate ability to lead others without formal authority, with demonstrated experience guiding teams from design to implementation of strategic initiatives.
Excellent communication skills, both verbal and in written.
Willingness and ability to travel as business dictates, both for internal and external functions.

Nice To Haves

Board certification or board eligibility in cardiovascular, neurology, critical care medicine preferred.
7 years work experience in the pharmaceutical sector in Medical Affairs, Clinical Development or related positions.
Experience in the field of medical support of a product portfolio across multiple therapeutic areas.
Experience in leading and participating in teams across cultures and geographies, prior experience in global medical launch planning activities.

Responsibilities

Oversee US medical affairs strategy and contributions into the Bayer pipeline portfolio in collaboration with the medical directors and in alignment with the VP of Specialty and Pipeline TA. This includes assets in development in diverse therapeutic areas.
Provide input, appropriate to the Phase of development of a product to ensure US perspective and needs are incorporated into development strategy.
Active participation and effective collaboration with global teams to assure the efficient and expedient conduct of clinical development programs, aligning them with strategic priorities that support appropriate US direction of the Life Cycle Management strategy.
Work collaboratively with US New Product Commercialization, Market Access and US regulatory teams to provide expert medical input into strategic plans.
Serve as a member of Product Team and/or Clinical Strategy Team leadership of multiple assets in different therapeutic areas.
Support development and execution of the US medical strategy, offering critical inputs during design and throughout the end-to-end execution of programs, in alignment with senior medical leadership.
Collaborate cross-functionally with Global Evidence Generation, Clinical Development, Regulatory, Commercial and other medical affairs partners to develop and implement the Integrated Evidence Plans to improve the value proposition for the portfolio.
Contribute to publication planning, data interpretation, and scientific dissemination in the US.
Provide medical scientific input for brand and program documents, including integrated disease area plans, medical information documents, drug safety reporting documents, etc, while ensuring design and execution of all medical activities are according to internal and external compliance guidelines.
Monitor and understand implications of evolving competitor landscape to inform medical strategy.
Support completion of annual New Drug Application (NDA) reports for respective brands through evaluation of clinical data and literature and provide US Medical Affairs input in the preparation of key medical documents for INDs and NDAs. This includes ensuring appropriate US Medical Affairs input in interactions with the FDA and providing appropriate medical leadership for any interactions.
Develop and guide local Thought Leader (TL) engagement strategy, together with cross-functional partners.
Serve as the US medical expert engaging thought leaders, academic institutions, medical societies, and patient advocacy groups to advance scientific leadership and collaboration.
Lead and support advisory boards, including agenda development, faculty engagement and synthesis of insights to help inform medical strategy.
Represent US Medical Affairs at major congresses, symposia and scientific forums.
Participate and may take on active leadership in the planning and administration of activities concerned with the clinical evaluation of drugs in development for the purpose of obtaining an approved Investigational New Drug (IND) or New Drug Application (NDA).